Soft Tissue Repair Market is Awaited to Grow at a high CAGR over the forecast period 2021 and 2027

In tissue repair, the missing tissue is replaced with granulated tissue, which grows into scar tissue over time. Bleeding, inflammation, proliferation, and tissue re-modelling are the four steps of tissue repair. Regeneration is the process by which healing occurs by the growth of residual cells, or cells that have not been harmed.

Statistics:

The global soft tissue repair market is estimated to account for US$ 5,932.0 Mn in terms of value by the end of 2020.

Get Sample Here

Global Soft Tissue Repair Market: Drivers

The worldwide soft tissue repair market is expected to develop due to an increase in the number of sports-related injuries. According to the National High School Sports-Related Injury Surveillance Study 2017-2018, there were 1,367,490 sports-related injury cases reported in high schools across the United States.

Global Soft Tissue Repair Market: Opportunities

For companies in the worldwide soft tissue repair market, R&D in hydrogel composite biomaterials is likely to offer lucrative growth prospects. For example, researchers at the University of Illinois at Urbana-Champaign in the United States presented a unique tissue reinforcement approach in August 2020: a stratified scaffold with osseous and tendinous tissue compartments connected by a continuous polyethylene glycol (PEG) hydrogel interface.

Global Soft Tissue Repair Market: Restraints

The worldwide soft tissue repair industry is projected to be hampered by ethical concerns and a lack of defined tissue engineering guidelines. The scarcity of human tissue in different parts of the world is impeding the development and approval of soft tissue repair therapies. This is primarily due to ethical considerations stemming from a strong cultural aversion to using human corpse tissue.

Key Takeaways:

Between 2020 and 2027, the global soft tissue repair market is expected to grow at a CAGR of 5.6 percent, from $5,618.7 million in 2019 to $8,702.5 million in 2027. Over the projected period, the worldwide soft tissue repair market is expected to develop due to an increase in the number of sports-related injuries. In 2019, the allograft segment dominated the global soft tissue repair market, accounting for 41.0 percent of market value. Growing research and development, as well as increasing product approval, are likely to aid the segment’s expansion throughout the forecast period.

Market Trends

The worldwide soft tissue repair market is expected to rise due to the high prevalence of breast cancer. According to the American Cancer Society, roughly 276,480 new instances of invasive breast cancer would be identified in women in 2020, resulting in 42,170 deaths in the United States. The market is witnessing entry of new market players. For instance, in September 2020, Venus Medtech (Hangzhou) Inc. a transcatheter heart valve medical device player in China, together with its subsidiaries, the “Group”, stock code: 2500) and Jilin Changchun Haoyue Halal Meat Co., Ltd., established a joint venture company, Venus Haoyue Medtech Limited. Venus Haoyue Medtech will be engaged in the design, research and development, manufacturing, sales, and technical services of high-end cardiovascular disease implant devices and surgical soft tissue repair materials.

Regulations

Europe

Europe’s translational pipeline regulations cover everything from fundamental research through the delivery of new regenerative and stem cell-based medicines. A variety of European legal instruments cover the translational pipeline from basic research to the delivery of innovative stem cell-based and regenerative therapies, ranging from marketing authorization regulations (Regulation (EC) no. 1394/2007) to clinical trial directives (Directive 2001/20/EC) and good clinical practise guidelines (Directive 2001/83/EC, Directive 2009/12).

Japan

• Japan regulations for cells/tissue-engineered (manipulated) products

• NA (PFSB notifications No. 0208003/2008 and No. 0912006/2008)

A drug or medical device that contains or is made up of manipulated autologous or allogeneic human cells and tissue that has undergone chemical treatment, has had biological properties altered, or has been combined with genetic engineering to artificially proliferate or activate cells and tissue for the purpose of curing disease, repairing, or regenerating tissues.

Global Soft Tissue Repair Market: Competitive Landscape   

B. Braun Melsungen AG, Baxter, BD, Johnson & Johnson Private Limited, Stryker Corp., Integra LifeSciences Corporation, Medtronic plc, Acera Surgical, Inc., Anthrex, Inc., Acelity L.P. Inc., Biorez, Aroa Biosurgery Limited, Misonix, Inc., and Ortho Regenerative Technologies Inc. are some of the major players in the global soft tissue repair market.

Global Soft Tissue Repair Market: Key Developments

To increase their market share, major companies in the global soft tissue repair market are focusing on various inorganic tactics. Ortho Regenerative Technologies Inc., an orthobiologics firm focused on the development of innovative soft tissue repair regenerative technologies, for example, announced the closure of a non-brokered US$ 2.5 million private offering of units in August 2020.

Segmentation

Scope of the report

• Global Soft Tissue Repair Market, By Product Type:

  • Synthetic

  • Allograft

  • Xenograft

  • Alloplast

• Global Soft Tissue Repair Market, By Application:

  • Breast Reconstruction

  • Hernia

  • Dermatology

  • Orthopedics

  • Dental

  • Vaginal Sling

  • Others

• Global Soft Tissue Repair Market, By End User:

  • Hospitals

  • Ambulatory Surgical Centers

  • Clinics

• Global Soft Tissue Repair Market, By Region:

  • North America

    • By Product Type:

      • Needle-based Biopsy Guns

      • Biopsy Needles

      • Biopsy Forceps

      • Biopsy Guidance Systems

      • Others

    • By Application

      • Breast Reconstruction

      • Hernia

      • Dermatology

      • Orthopedics

      • Dental

      • Vaginal Sling

      • Others

    • By End User

      • Hospitals

      • Ambulatory Surgical Centers

      • Clinics

• • By Country

    • U.S.

    • Canada

  • Latin America

    • By Product Type:

      • Needle-based Biopsy Guns

      • Biopsy Needles

      • Biopsy Forceps

      • Biopsy Guidance Systems

      • Others

    • By Application

      • Breast Reconstruction

      • Hernia

      • Dermatology

      • Orthopedics

      • Dental

      • Vaginal Sling

      • Others

    • By End User

      • Hospitals

      • Ambulatory Surgical Centers

      • Clinics

    • By Country

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

  • Europe

    • By Product Type:

      • Needle-based Biopsy Guns

      • Biopsy Needles

      • Biopsy Forceps

      • Biopsy Guidance Systems

      • Others

    • By Application

      • Breast Reconstruction

      • Hernia

      • Dermatology

      • Orthopedics

      • Dental

      • Vaginal Sling

      • Others

    • By End User

      • Hospitals

      • Ambulatory Surgical Centers

      • Clinics

    • By Country

      • U.K.

      • Germany

      • France

      • Spain

      • Italy

      • Russia

      • Rest of Europe

  • Asia Pacific

    • By Product Type:

      • Needle-based Biopsy Guns

      • Biopsy Needles

      • Biopsy Forceps

      • Biopsy Guidance Systems

      • Others

    • By Application

      • Breast Reconstruction

      • Hernia

      • Dermatology

      • Orthopedics

      • Dental

      • Vaginal Sling

      • Others

    • By End User

      • Hospitals

      • Ambulatory Surgical Centers

      • Clinics

    • By Country

      • China

      • Japan

      • India

      • Australia

      • South Korea

      • ASEAN

      • Rest of Asia Pacific

  • Middle East

    • By Product Type:

      • Needle-based Biopsy Guns

      • Biopsy Needles

      • Biopsy Forceps

      • Biopsy Guidance Systems

      • Others

    • By Application

      • Breast Reconstruction

      • Hernia

      • Dermatology

      • Orthopedics

      • Dental

      • Vaginal Sling

      • Others

    • By End User

      • Hospitals

      • Ambulatory Surgical Centers

      • Clinics

    • By Country

      • GCC Countries

      • Israel

      • Rest of Middle East

  • Africa

    • By Product Type:

      • Needle-based Biopsy Guns

      • Biopsy Needles

      • Biopsy Forceps

      • Biopsy Guidance Systems

      • Others

    • By Application

      • Breast Reconstruction

      • Hernia

      • Dermatology

      • Orthopedics

      • Dental

      • Vaginal Sling

      • Others

    • By End User

      • Hospitals

      • Ambulatory Surgical Centers

      • Clinics

    • By Country

      • North Africa

      • Central Africa

      • South Africa

• Company Profiles

  • B. Braun Melsungen AG *

    • Company Overview

    • Product Portfolio

    • Key Highlights

    • Financial Overview

    • Strategies

  • Baxter

  • BD

  • Johnson & Johnson Private Limited

  • Stryker Corp.

  • Integra LifeSciences Corporation

  • Medtronic plc.

  • Acera Surgical, Inc.

  • Anthrex, Inc.

  • Acelity L.P. Inc.

  • Biorez

  • Aroa Biosurgery Limited

  • Misonix, Inc.

  • Ortho Regenerative Technologies Inc.

Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/1694

Main points in Soft Tissue Repair Market Report Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Soft Tissue Repair Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Soft Tissue Repair Industry Impact

Chapter 2 Global Soft Tissue Repair Competition by Types, Applications, and Top Regions and Countries
2.1 Global Soft Tissue Repair (Volume and Value) by Type
2.3 Global Soft Tissue Repair (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Soft Tissue Repair Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Soft Tissue Repair Market Analysis
Chapter 6 East Asia Soft Tissue Repair Market Analysis
Chapter 7 Europe Soft Tissue Repair Market Analysis
Chapter 8 South Asia Soft Tissue Repair Market Analysis
Chapter 9 Southeast Asia Soft Tissue Repair Market Analysis
Chapter 10 Middle East Soft Tissue Repair Market Analysis
Chapter 11 Africa Soft Tissue Repair Market Analysis
Chapter 12 Oceania Soft Tissue Repair Market Analysis
Chapter 13 South America Soft Tissue Repair Market Analysis
Chapter 14 Company Profiles and Key Figures in Soft Tissue Repair Business
Chapter 15 Global Soft Tissue Repair Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com